Miodrag Stojković completed studying Veterinary Medicine in 1990 at the University of Belgrade, Serbia. In 1991 he went to Germany, where he first worked for two years as a male nurse at the University Hospital of Hamburg. In 1993, he moved to Munich where he received his doctorate and habil degrees from the Ludwig-Maximilians University in 1996 and 2002, respectively. During this time he was working with research interest in early mammalian embryology, cell biology, nuclear transfer, and epigenetics. In 2002, he moved to UK and joined the team at the Medical School of the University of Newcastle where he was appointed as Chair in Embryology and Stem Cell Biology and Deputy Director of the Centre for Stem Cell Biology & Developmental Genetics in 2005. In 2006, he joined the Research Centre Prince Felipe in Valencia, Spain where he was working until 2010 as Deputy Director and Head of Cellular Reprogramming lab. In 2007, he was appointed Professor of Human Genetics at the Medical School, University of Kragujevac, Serbia. In 2008, in Leskovac, he founded Spebo Medical, a special hospital for fertility treatments.
Dr. Stojkovic is a pioneer in human nuclear transfer (NT), reprogramming, derivation, growth, differentiation and application of human embryonic stem cells (hESC) and adult stem cells. In 2003 he derived UK’s first fully characterised hESC line and in 2004 he was granted the first licence in the Western World to perform human NT. Currently, his team is improving the conditions for the efficient reprogramming of adult cells, targeted differentiation of hESC, induced pluripotency cells, isolation of peripheral blood stem cells and mesenchymal stem cells, and treatment of neurodegenerative diseases.
He is visiting professor at one Medical School, one Military Medical Academy, and author and co-author of more than 120 scientific publications. He served as a scientific adviser in several biotech companies, is academic reviewer for more than thirty grant/regulation bodies and scientific journals and till 01/01/2012 was Editor of STEM CELLS (Durham, North Carolina). Currently he also serves as a President of Board of Institute of Molecular Genetics and Genetic Engineering (Belgrade, Serbia).